Neoalbaconol inhibits angiogenesis and tumor growth by suppressing EGFR-mediated VEGF production.


Neoalbaconol, derived from Albatrellus confluens, shows anti-cancer activities in the previously study, but its role in angiogenesis is unknown. Here, we determined whether neoalbaconol could attenuate angiogenesis and how does it occur. Data demonstrated that neoalbaconol could inhibit the proliferation of breast cancer cells and induce apoptosis. Also… (More)
DOI: 10.1002/mc.22602